ASND Ascendis Pharma A/S

-0.71  -1%
Previous Close 112.67
Open 113.34
Price To Book 6.52
Market Cap 5,323,161,040
Shares 47,545,204
Volume 244,226
Short Ratio
Av. Daily Volume 347,618

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data released March 4, 2019. Primary endpoint met with detailed data released June 26, 2019.
TransCon hGH
Growth hormone deficiency in children
Phase 2 top-line data due 4Q 2019.
Phase 2 trial to be initiated 3Q 2019.
TransCon CNP

Latest News

  1. Ascendis Pharma A/S Announces R&D Day on June 26 to Review Endocrinology Rare Disease Pipeline and Introduce Oncology Programs
  2. Hedge Funds Have Never Been This Bullish On Ascendis Pharma A/S (ASND)
  3. Edited Transcript of ASND earnings conference call or presentation 30-May-19 8:30pm GMT
  4. Ascendis Pharma A/S Reports First Quarter 2019 Financial Results
  5. Ascendis Pharma A/S to Host Earnings Call
  6. Ascendis Pharma A/S Announces Preliminary Data from Single Arm Phase 3 fliGHt Trial Demonstrated TransCon™ hGH was Safe and Well-Tolerated in Pediatric Subjects Previously Treated with Daily Growth Hormone
  7. Ascendis Pharma A/S Announces First Quarter 2019 Financial Results and Business Update Conference Call on May 30
  8. Ascendis Pharma A/S Announces Participation in the Bank of America Merrill Lynch 2019 Healthcare Conference
  9. Wyndham Hotels & Resorts, Inc. (WH): 2019 Sohn Conference New York Recap
  10. What You Must Know About Ascendis Pharma A/S's (NASDAQ:ASND) Financial Health
  11. Did Hedge Funds Drop The Ball On Ascendis Pharma A/S (ASND) ?
  12. Glenview Capital Management’s Stock Pitches At 2018 Sohn Conference
  13. Ascendis Pharma A/S Announces Presentations Related to Rare Disease Endocrinology Pipeline at Upcoming Medical Conferences
  14. Joseph Jolson’s Harvest Capital Strategies’ Return, AUM, and Holdings
  15. Best Stock Pick From The 2018 Sohn Conference (Part II)
  16. Edited Transcript of ASND earnings conference call or presentation 3-Apr-19 8:30pm GMT
  17. What Happened With Light Street’s Glen Kacher’s Best Idea at 2018 Sohn Conference?
  18. Sarissa Capital Management Hires New President
  19. Ascendis Pharma A/S (ASND) Q4 2018 Earnings Conference Call Transcript
  20. Ascendis Pharma A/S Reports Full Year 2018 Financial Results